Revelation Biosciences, Inc. (REVB) stock
REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.82−0.44 (-10.43%)
Close on Nov 16, 2026Market cap $15.22MP/E –Yield –
Revelation Biosciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Revelation Biosciences
Revelation Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?